These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1648700)

  • 1. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
    Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
    Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptor alpha suppresses polyomavirus transformation and c-fos expression in rat fibroblasts.
    Talmage DA; Lackey RS
    Oncogene; 1992 Sep; 7(9):1837-45. PubMed ID: 1380150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of AP-1 constitutive activity interferes with polyomavirus MT antigen transformation ability.
    Winnischofer SM; de Oliveira ML; Sogayar MC
    J Cell Biochem; 2003 Oct; 90(2):253-66. PubMed ID: 14505342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
    Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
    Sonobe MH; Bravo R; Armelin MS
    Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
    Urich M; Senften M; Shaw PE; Ballmer-Hofer K
    Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
    Braun L; Dürst M; Mikumo R; Gruppuso P
    Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-1 Tax induces expression of various immediate early serum responsive genes.
    Fujii M; Niki T; Mori T; Matsuda T; Matsui M; Nomura N; Seiki M
    Oncogene; 1991 Jun; 6(6):1023-9. PubMed ID: 1906155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus tumorantigens have a profound effect on gene expression in mouse fibroblasts.
    Klucky B; Koch B; Radolf M; Steinlein P; Wintersberger E
    Oncogene; 2004 Jun; 23(27):4707-21. PubMed ID: 15122341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The half-lives of platelet-derived growth factor A- and B-chain mRNAs are similar in endothelial cells and unaffected by heparin-binding growth factor-1 or cycloheximide.
    Gay CG; Winkles JA
    J Cell Physiol; 1991 Apr; 147(1):121-7. PubMed ID: 1709940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor.
    Zwiller J; Sassone-Corsi P; Kakazu K; Boynton AL
    Oncogene; 1991 Feb; 6(2):219-21. PubMed ID: 1900355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.